 James Forrest
Concepts (262)
Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Rhadinovirus | 11 | 2025 | 22 | 4.120 |
Why?
| | Gammaherpesvirinae | 12 | 2024 | 21 | 3.060 |
Why?
| | B-Lymphocytes | 11 | 2025 | 184 | 2.730 |
Why?
| | Herpesviridae Infections | 12 | 2025 | 57 | 2.660 |
Why?
| | Virus Latency | 17 | 2025 | 53 | 2.580 |
Why?
| | Virus Replication | 16 | 2023 | 150 | 2.450 |
Why?
| | Viral Proteins | 9 | 2020 | 164 | 2.430 |
Why?
| | Virus Activation | 10 | 2022 | 39 | 2.100 |
Why?
| | Immediate-Early Proteins | 3 | 2022 | 18 | 1.880 |
Why?
| | Tumor Suppressor Protein p53 | 3 | 2025 | 221 | 1.490 |
Why?
| | Host-Pathogen Interactions | 4 | 2019 | 144 | 1.410 |
Why?
| | Antigens, Viral | 5 | 2017 | 43 | 1.240 |
Why?
| | Herpesvirus 4, Human | 4 | 2025 | 43 | 1.200 |
Why?
| | Herpesvirus 8, Human | 6 | 2024 | 98 | 1.190 |
Why?
| | Nuclear Proteins | 4 | 2017 | 245 | 1.100 |
Why?
| | Germinal Center | 2 | 2025 | 30 | 1.100 |
Why?
| | Trans-Activators | 2 | 2017 | 135 | 1.020 |
Why?
| | Mice | 32 | 2025 | 5949 | 0.980 |
Why?
| | Cell Proliferation | 2 | 2025 | 1023 | 0.830 |
Why?
| | Signal Transduction | 8 | 2019 | 1671 | 0.810 |
Why?
| | Gene Expression Regulation, Viral | 8 | 2020 | 49 | 0.790 |
Why?
| | Animals | 36 | 2025 | 13505 | 0.770 |
Why?
| | Mice, Inbred C57BL | 11 | 2025 | 1884 | 0.730 |
Why?
| | Cytidine Deaminase | 1 | 2020 | 12 | 0.710 |
Why?
| | Reoviridae | 7 | 2005 | 25 | 0.680 |
Why?
| | Sarcoma, Kaposi | 4 | 2024 | 76 | 0.660 |
Why?
| | Tumor Virus Infections | 4 | 2025 | 48 | 0.590 |
Why?
| | Antigens, Nuclear | 1 | 2018 | 24 | 0.580 |
Why?
| | Cell Line | 12 | 2017 | 1030 | 0.580 |
Why?
| | Helper Viruses | 1 | 2017 | 6 | 0.550 |
Why?
| | Codon | 1 | 2017 | 43 | 0.540 |
Why?
| | Genetic Engineering | 1 | 2017 | 23 | 0.540 |
Why?
| | Cell Adhesion Molecules | 8 | 2006 | 86 | 0.530 |
Why?
| | Epstein-Barr Virus Infections | 3 | 2024 | 32 | 0.500 |
Why?
| | Receptors, Virus | 6 | 2006 | 26 | 0.430 |
Why?
| | Phosphoproteins | 1 | 2013 | 119 | 0.400 |
Why?
| | MAP Kinase Kinase 4 | 1 | 2012 | 29 | 0.400 |
Why?
| | 3T3 Cells | 3 | 2018 | 58 | 0.390 |
Why?
| | Models, Biological | 3 | 2013 | 735 | 0.390 |
Why?
| | Cells, Cultured | 6 | 2025 | 1567 | 0.370 |
Why?
| | HEK293 Cells | 5 | 2019 | 229 | 0.360 |
Why?
| | Herpesviridae | 3 | 2020 | 19 | 0.330 |
Why?
| | Orthoreovirus, Mammalian | 4 | 2018 | 17 | 0.320 |
Why?
| | Proviruses | 1 | 2008 | 2 | 0.300 |
Why?
| | Virology | 1 | 2008 | 6 | 0.300 |
Why?
| | Promoter Regions, Genetic | 4 | 2019 | 467 | 0.290 |
Why?
| | Genome, Viral | 3 | 2020 | 83 | 0.270 |
Why?
| | Antigens, Neoplasm | 1 | 2007 | 147 | 0.260 |
Why?
| | Capsid Proteins | 4 | 2018 | 24 | 0.260 |
Why?
| | DNA Damage | 1 | 2008 | 305 | 0.260 |
Why?
| | Receptors, Cell Surface | 2 | 2003 | 118 | 0.250 |
Why?
| | Antiviral Agents | 2 | 2019 | 178 | 0.250 |
Why?
| | Mice, Knockout | 4 | 2025 | 879 | 0.240 |
Why?
| | Mutagenesis | 2 | 2018 | 61 | 0.240 |
Why?
| | NIH 3T3 Cells | 3 | 2018 | 51 | 0.240 |
Why?
| | Neoplasm Proteins | 1 | 2007 | 334 | 0.230 |
Why?
| | DNA, Viral | 3 | 2023 | 137 | 0.230 |
Why?
| | Fibroblasts | 5 | 2017 | 355 | 0.220 |
Why?
| | Female | 7 | 2025 | 28171 | 0.200 |
Why?
| | Humans | 27 | 2024 | 52483 | 0.190 |
Why?
| | Protein Binding | 5 | 2015 | 667 | 0.180 |
Why?
| | Tandem Mass Spectrometry | 2 | 2013 | 251 | 0.180 |
Why?
| | Apoptosis | 6 | 2014 | 1119 | 0.180 |
Why?
| | Lymphoid Tissue | 1 | 2020 | 20 | 0.180 |
Why?
| | Antigens, CD19 | 1 | 2020 | 28 | 0.180 |
Why?
| | Autoantibodies | 1 | 2021 | 121 | 0.170 |
Why?
| | Antigens, Bacterial | 1 | 2020 | 54 | 0.170 |
Why?
| | Cell Differentiation | 2 | 2020 | 665 | 0.170 |
Why?
| | Histamine | 1 | 2019 | 25 | 0.160 |
Why?
| | N-Acetylneuraminic Acid | 4 | 2003 | 13 | 0.160 |
Why?
| | Gene Deletion | 2 | 2015 | 272 | 0.160 |
Why?
| | Programmed Cell Death 1 Ligand 2 Protein | 1 | 2019 | 4 | 0.160 |
Why?
| | Interferon Regulatory Factors | 1 | 2019 | 18 | 0.160 |
Why?
| | Programmed Cell Death 1 Receptor | 1 | 2019 | 41 | 0.160 |
Why?
| | Burkitt Lymphoma | 1 | 2019 | 27 | 0.160 |
Why?
| | Interleukin-1beta | 2 | 2019 | 86 | 0.150 |
Why?
| | Mycobacterium tuberculosis | 1 | 2020 | 291 | 0.150 |
Why?
| | Chaperonin Containing TCP-1 | 1 | 2018 | 1 | 0.150 |
Why?
| | Capsid | 1 | 2018 | 2 | 0.150 |
Why?
| | Virus Assembly | 1 | 2018 | 4 | 0.150 |
Why?
| | Male | 5 | 2025 | 26761 | 0.150 |
Why?
| | Embryo, Mammalian | 1 | 2018 | 67 | 0.140 |
Why?
| | Gene Knock-In Techniques | 1 | 2017 | 22 | 0.140 |
Why?
| | Organ Specificity | 1 | 2018 | 115 | 0.140 |
Why?
| | Herpesvirus Vaccines | 1 | 2017 | 1 | 0.140 |
Why?
| | Base Pairing | 1 | 2017 | 27 | 0.140 |
Why?
| | Bacterial Proteins | 1 | 2020 | 361 | 0.130 |
Why?
| | Homologous Recombination | 1 | 2017 | 41 | 0.130 |
Why?
| | Mice, SCID | 1 | 2017 | 182 | 0.130 |
Why?
| | Mammalian orthoreovirus 3 | 3 | 2006 | 11 | 0.130 |
Why?
| | Amino Acid Sequence | 4 | 2012 | 578 | 0.130 |
Why?
| | Molecular Sequence Data | 4 | 2012 | 778 | 0.130 |
Why?
| | Mice, Transgenic | 1 | 2018 | 552 | 0.130 |
Why?
| | Spleen | 3 | 2015 | 172 | 0.130 |
Why?
| | Centrifugation | 1 | 2015 | 12 | 0.130 |
Why?
| | Protein Interaction Maps | 1 | 2015 | 27 | 0.120 |
Why?
| | Immunoprecipitation | 1 | 2015 | 57 | 0.120 |
Why?
| | Isotope Labeling | 1 | 2015 | 57 | 0.120 |
Why?
| | Chronic Disease | 1 | 2018 | 586 | 0.120 |
Why?
| | Caspase 1 | 1 | 2015 | 23 | 0.120 |
Why?
| | HIV Infections | 1 | 2019 | 389 | 0.120 |
Why?
| | Cell Line, Tumor | 4 | 2020 | 1470 | 0.120 |
Why?
| | Caspases | 1 | 2015 | 104 | 0.110 |
Why?
| | Murine hepatitis virus | 1 | 2014 | 17 | 0.110 |
Why?
| | Coronavirus | 1 | 2014 | 17 | 0.110 |
Why?
| | Computational Biology | 2 | 2013 | 212 | 0.110 |
Why?
| | Protein Processing, Post-Translational | 1 | 2015 | 153 | 0.110 |
Why?
| | Junctional Adhesion Molecules | 5 | 2006 | 5 | 0.110 |
Why?
| | Phosphorylation | 1 | 2015 | 528 | 0.110 |
Why?
| | Small Molecule Libraries | 1 | 2014 | 67 | 0.110 |
Why?
| | Mass Spectrometry | 1 | 2015 | 292 | 0.110 |
Why?
| | Reoviridae Infections | 2 | 2005 | 21 | 0.110 |
Why?
| | Inflammasomes | 1 | 2015 | 66 | 0.110 |
Why?
| | CHO Cells | 5 | 2006 | 125 | 0.110 |
Why?
| | Cricetinae | 5 | 2006 | 194 | 0.110 |
Why?
| | Drug Discovery | 1 | 2014 | 93 | 0.110 |
Why?
| | Cyclin D | 1 | 2013 | 18 | 0.110 |
Why?
| | Proto-Oncogene Proteins c-jun | 1 | 2013 | 75 | 0.110 |
Why?
| | Proto-Oncogene Proteins c-bcl-2 | 1 | 2014 | 129 | 0.100 |
Why?
| | Algorithms | 1 | 2017 | 672 | 0.100 |
Why?
| | MAP Kinase Signaling System | 1 | 2013 | 121 | 0.100 |
Why?
| | Protein Interaction Domains and Motifs | 1 | 2012 | 21 | 0.100 |
Why?
| | Chromatography, High Pressure Liquid | 1 | 2013 | 339 | 0.100 |
Why?
| | Models, Molecular | 2 | 2003 | 348 | 0.100 |
Why?
| | Proteome | 1 | 2013 | 171 | 0.090 |
Why?
| | Proteomics | 1 | 2013 | 329 | 0.090 |
Why?
| | Genes, Immediate-Early | 1 | 2010 | 5 | 0.080 |
Why?
| | Virus Integration | 1 | 2010 | 9 | 0.080 |
Why?
| | Flow Cytometry | 3 | 2014 | 478 | 0.080 |
Why?
| | DNA | 1 | 2012 | 549 | 0.080 |
Why?
| | Transcriptome | 1 | 2012 | 370 | 0.080 |
Why?
| | High-Throughput Screening Assays | 2 | 2019 | 38 | 0.080 |
Why?
| | Transcription Initiation Site | 1 | 2008 | 14 | 0.080 |
Why?
| | Toll-Like Receptors | 1 | 2008 | 27 | 0.080 |
Why?
| | Transfection | 3 | 2006 | 357 | 0.080 |
Why?
| | Polymerase Chain Reaction | 2 | 2014 | 461 | 0.070 |
Why?
| | Etoposide | 1 | 2008 | 74 | 0.070 |
Why?
| | Antineoplastic Agents, Phytogenic | 1 | 2008 | 71 | 0.070 |
Why?
| | MART-1 Antigen | 1 | 2007 | 12 | 0.070 |
Why?
| | Lung | 3 | 2020 | 509 | 0.070 |
Why?
| | Vero Cells | 1 | 2007 | 44 | 0.070 |
Why?
| | Mutation | 1 | 2013 | 1347 | 0.070 |
Why?
| | Green Fluorescent Proteins | 1 | 2007 | 93 | 0.070 |
Why?
| | Tight Junctions | 2 | 2005 | 26 | 0.070 |
Why?
| | Endothelial Cells | 2 | 2020 | 262 | 0.070 |
Why?
| | Transcription, Genetic | 1 | 2008 | 378 | 0.070 |
Why?
| | Mammals | 2 | 2023 | 61 | 0.070 |
Why?
| | Dimerization | 2 | 2003 | 51 | 0.070 |
Why?
| | Gene Expression Profiling | 1 | 2012 | 1105 | 0.070 |
Why?
| | Phenotype | 3 | 2003 | 789 | 0.060 |
Why?
| | Antibodies, Viral | 2 | 2022 | 109 | 0.060 |
Why?
| | Protein Structure, Tertiary | 2 | 2003 | 242 | 0.060 |
Why?
| | NF-kappa B p50 Subunit | 1 | 2005 | 17 | 0.060 |
Why?
| | Transcription Factors | 1 | 2008 | 566 | 0.060 |
Why?
| | Macrophages | 3 | 2015 | 379 | 0.060 |
Why?
| | HeLa Cells | 4 | 2006 | 265 | 0.050 |
Why?
| | Uracil | 1 | 2023 | 6 | 0.050 |
Why?
| | Uracil-DNA Glycosidase | 1 | 2023 | 7 | 0.050 |
Why?
| | Carbohydrate Metabolism | 1 | 2003 | 23 | 0.050 |
Why?
| | Cross-Linking Reagents | 1 | 2003 | 43 | 0.050 |
Why?
| | STAT3 Transcription Factor | 1 | 2024 | 85 | 0.050 |
Why?
| | Mutagenesis, Site-Directed | 1 | 2003 | 95 | 0.050 |
Why?
| | Point Mutation | 1 | 2003 | 67 | 0.050 |
Why?
| | Biliary Atresia | 1 | 2003 | 9 | 0.050 |
Why?
| | Enzyme-Linked Immunosorbent Assay | 1 | 2003 | 235 | 0.050 |
Why?
| | DNA-Directed DNA Polymerase | 1 | 2023 | 89 | 0.050 |
Why?
| | Lymphocytes | 1 | 2003 | 153 | 0.050 |
Why?
| | Serologic Tests | 1 | 2022 | 25 | 0.050 |
Why?
| | DNA Replication | 1 | 2023 | 160 | 0.050 |
Why?
| | Structure-Activity Relationship | 1 | 2003 | 404 | 0.050 |
Why?
| | Seroepidemiologic Studies | 1 | 2022 | 44 | 0.050 |
Why?
| | Caco-2 Cells | 2 | 2018 | 31 | 0.050 |
Why?
| | Peptidyl-Dipeptidase A | 1 | 2021 | 27 | 0.050 |
Why?
| | Receptor, Angiotensin, Type 1 | 1 | 2021 | 56 | 0.050 |
Why?
| | Renin-Angiotensin System | 1 | 2021 | 56 | 0.050 |
Why?
| | Membrane Fusion | 1 | 2000 | 10 | 0.040 |
Why?
| | Angiotensin II | 1 | 2021 | 162 | 0.040 |
Why?
| | Receptors, Histamine | 1 | 2019 | 7 | 0.040 |
Why?
| | Lymphocyte Activation | 2 | 2012 | 172 | 0.040 |
Why?
| | Time Factors | 2 | 2003 | 2968 | 0.040 |
Why?
| | Databases, Genetic | 1 | 2020 | 83 | 0.040 |
Why?
| | Tumor Escape | 1 | 2019 | 17 | 0.040 |
Why?
| | Virulence Factors | 1 | 2020 | 80 | 0.040 |
Why?
| | HIV | 1 | 2019 | 25 | 0.040 |
Why?
| | Drug Evaluation, Preclinical | 1 | 2019 | 146 | 0.040 |
Why?
| | Coinfection | 1 | 2019 | 47 | 0.040 |
Why?
| | Protein Folding | 1 | 2018 | 50 | 0.040 |
Why?
| | RNA Interference | 1 | 2018 | 181 | 0.030 |
Why?
| | RNA, Small Interfering | 1 | 2018 | 213 | 0.030 |
Why?
| | Cross-Sectional Studies | 1 | 2022 | 1678 | 0.030 |
Why?
| | Genes, Viral | 2 | 2006 | 39 | 0.030 |
Why?
| | Salmonella typhimurium | 1 | 2015 | 42 | 0.030 |
Why?
| | Interferons | 1 | 2015 | 40 | 0.030 |
Why?
| | Caspases, Initiator | 1 | 2015 | 12 | 0.030 |
Why?
| | Hexachlorophene | 1 | 2014 | 2 | 0.030 |
Why?
| | Harringtonines | 1 | 2014 | 3 | 0.030 |
Why?
| | Nitro Compounds | 1 | 2014 | 8 | 0.030 |
Why?
| | Cohort Studies | 1 | 2019 | 1542 | 0.030 |
Why?
| | Luciferases | 1 | 2014 | 48 | 0.030 |
Why?
| | Virus Internalization | 1 | 2014 | 20 | 0.030 |
Why?
| | Thiazoles | 1 | 2014 | 55 | 0.030 |
Why?
| | Gene Expression Regulation | 1 | 2019 | 990 | 0.030 |
Why?
| | Adult | 2 | 2022 | 14161 | 0.030 |
Why?
| | Viral Load | 1 | 2014 | 82 | 0.030 |
Why?
| | Receptors, Antigen, B-Cell | 1 | 2014 | 7 | 0.030 |
Why?
| | Sequence Homology, Amino Acid | 2 | 2005 | 140 | 0.030 |
Why?
| | Lipopolysaccharides | 1 | 2015 | 206 | 0.030 |
Why?
| | Animals, Newborn | 2 | 2005 | 362 | 0.030 |
Why?
| | Microscopy, Fluorescence | 1 | 2014 | 160 | 0.030 |
Why?
| | Repression, Psychology | 1 | 2012 | 1 | 0.030 |
Why?
| | Terminal Repeat Sequences | 1 | 2012 | 10 | 0.030 |
Why?
| | Blotting, Western | 1 | 2014 | 590 | 0.020 |
Why?
| | Regulatory Elements, Transcriptional | 1 | 2012 | 8 | 0.020 |
Why?
| | Tetradecanoylphorbol Acetate | 1 | 2012 | 46 | 0.020 |
Why?
| | Open Reading Frames | 1 | 2012 | 55 | 0.020 |
Why?
| | Cell Survival | 1 | 2014 | 612 | 0.020 |
Why?
| | Disease Models, Animal | 1 | 2017 | 1478 | 0.020 |
Why?
| | Cluster Analysis | 1 | 2012 | 233 | 0.020 |
Why?
| | Tumor Cells, Cultured | 2 | 2003 | 460 | 0.020 |
Why?
| | Oligonucleotide Array Sequence Analysis | 1 | 2012 | 405 | 0.020 |
Why?
| | Receptors, Interferon | 1 | 2010 | 4 | 0.020 |
Why?
| | Administration, Intranasal | 1 | 2010 | 31 | 0.020 |
Why?
| | Plasmids | 1 | 2010 | 163 | 0.020 |
Why?
| | DNA-Binding Proteins | 1 | 2012 | 422 | 0.020 |
Why?
| | Immunity, Innate | 1 | 2010 | 117 | 0.020 |
Why?
| | Viral Plaque Assay | 1 | 2008 | 4 | 0.020 |
Why?
| | Reproducibility of Results | 1 | 2012 | 1229 | 0.020 |
Why?
| | Cytopathogenic Effect, Viral | 1 | 2006 | 5 | 0.020 |
Why?
| | Receptors, Fc | 1 | 2006 | 10 | 0.020 |
Why?
| | Sequence Deletion | 1 | 2006 | 73 | 0.020 |
Why?
| | DNA Methylation | 1 | 2010 | 592 | 0.020 |
Why?
| | In Situ Nick-End Labeling | 1 | 2005 | 53 | 0.020 |
Why?
| | Interferon-beta | 1 | 2005 | 33 | 0.020 |
Why?
| | Sequence Alignment | 1 | 2005 | 125 | 0.010 |
Why?
| | DNA Primers | 1 | 2005 | 208 | 0.010 |
Why?
| | Myocarditis | 1 | 2005 | 49 | 0.010 |
Why?
| | Recombinant Proteins | 1 | 2006 | 483 | 0.010 |
Why?
| | Intestines | 1 | 2005 | 154 | 0.010 |
Why?
| | Base Sequence | 1 | 2005 | 640 | 0.010 |
Why?
| | Intestinal Mucosa | 1 | 2005 | 224 | 0.010 |
Why?
| | Middle Aged | 1 | 2019 | 13028 | 0.010 |
Why?
| | Encephalitis, Viral | 1 | 2003 | 7 | 0.010 |
Why?
| | Bile Ducts | 1 | 2003 | 50 | 0.010 |
Why?
| | Heart | 1 | 2005 | 345 | 0.010 |
Why?
| | Virulence | 1 | 2003 | 167 | 0.010 |
Why?
| | Myocardium | 1 | 2005 | 453 | 0.010 |
Why?
| | Intercellular Junctions | 1 | 2001 | 7 | 0.010 |
Why?
| | Genotype | 1 | 2003 | 566 | 0.010 |
Why?
| | Protein Conformation | 1 | 2001 | 176 | 0.010 |
Why?
| | Chick Embryo | 1 | 2001 | 81 | 0.010 |
Why?
| | COS Cells | 1 | 2001 | 73 | 0.010 |
Why?
| | Gene Library | 1 | 2001 | 44 | 0.010 |
Why?
| | Surface Plasmon Resonance | 1 | 2000 | 23 | 0.010 |
Why?
| | DNA, Complementary | 1 | 2001 | 135 | 0.010 |
Why?
| | Cloning, Molecular | 1 | 2001 | 190 | 0.010 |
Why?
| | Biosensing Techniques | 1 | 2000 | 30 | 0.010 |
Why?
| | Cell Death | 1 | 2001 | 177 | 0.010 |
Why?
| | Recombinant Fusion Proteins | 1 | 2001 | 177 | 0.010 |
Why?
| | NF-kappa B | 1 | 2001 | 322 | 0.010 |
Why?
| | Kinetics | 1 | 2000 | 626 | 0.010 |
Why?
| | Tumor Necrosis Factor-alpha | 1 | 2001 | 399 | 0.010 |
Why?
| | Brain | 1 | 2005 | 1323 | 0.010 |
Why?
|
|
Forrest's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically based on a person's publications. Keywords from attributed publications are matched to keywords from the MeSH. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|